Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$277K Buy
1,907
+125
+7% +$17.3K 0.15% 79
2026
Q2
$229K Buy
1,782
+386
+28% +$45.2K 0.13% 92
2026
Q1
$168K Sell
1,396
-94
-6% -$10.9K 0.12% 99
2025
Q4
$157K Buy
1,490
+382
+34% +$35.9K 0.12% 119
2025
Q3
$93K Sell
1,108
-15
-1% -$1.24K 0.07% 175
2025
Q2
$88.9K Sell
1,123
-61
-5% -$4.85K 0.08% 179
2025
Q1
$106K Sell
1,184
-521
-31% -$48.6K 0.1% 154
2024
Q4
$170K Buy
+1,705
New +$176K 0.16% 110

Other funds holding MRK

WPG Advisers's MRK Position: Q3 2026 in Review

WPG Advisers increased its Merck (MRK) stake by 7% in Q3 2026, buying an estimated $17.3K and bringing the position to 1,907 shares worth $277K. The position accounts for 0.15% of the portfolio, ranked #79.

WPG Advisers first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 1,672 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • WPG Advisers held 1,907 shares of Merck worth $277K as of Q3 2026.
  • WPG Advisers bought 125 Merck shares in Q3 2026, an estimated $17.3K.
  • Merck made up 0.15% of WPG Advisers's portfolio in Q3 2026, its #79 holding.
  • WPG Advisers first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 1,672 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.